Cordis Corporation Release: Two-Year Data From INNOVATION Trial On INCRAFT® AAA Stent Graft System Continues To Demonstrate Safety And Performance In Treatment Of Abdominal Aortic Aneurysms

FREMONT, Calif.--(BUSINESS WIRE)--Cordis Corporation today announced the presentation of two-year data from its INNOVATION Trial at the 2014 Leipzig Interventional Course (LINC) in Germany. Data from the study continues to demonstrate that the INCRAFT® System performs well in patients suffering from abdominal aortic aneurysms (AAA) two years after treatment.

Help employers find you! Check out all the jobs and post your resume.